Cargando…

Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice

Mostrar otras versiones (1)

Equitable access to vaccines is necessary to limit the global impact of the coronavirus disease 2019 (COVID-19) pandemic and the emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. In previous studies, we described the development of a low-cost vaccine based on a...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Domínguez, Irene, Martínez, Jose Luis, Slamanig, Stefan, Lemus, Nicholas, Liu, Yonghong, Lai, Tsoi Ying, Carreño, Juan Manuel, Singh (a), Gagandeep, Singh (b), Gagandeep, Schotsaert, Michael, Mena, Ignacio, McCroskery, Stephen, Coughlan, Lynda, Krammer, Florian, García-Sastre, Adolfo, Palese, Peter, Sun, Weina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963686/ https://www.ncbi.nlm.nih.gov/pubmed/35350201 http://dx.doi.org/10.1101/2022.03.21.485247

Ejemplares similares

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice
por: González-Domínguez, Irene, et al.
Publicado: (2022)

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats
por: Tcheou, Johnstone, et al.
Publicado: (2021)

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
por: Sun, Weina, et al.
Publicado: (2020)

A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
por: Sun, Weina, et al.
Publicado: (2020)

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
por: Sun, Weina, et al.
Publicado: (2021)

Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies
por: Carreño, Juan Manuel, et al.
Publicado: (2023)

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2020)

Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
por: Amanat, Fatima, et al.
Publicado: (2021)

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico
por: Ponce-de-León, Samuel, et al.
Publicado: (2023)

Package of NDV-Pseudotyped HIV-Luc Virus and Its Application in the Neutralization Assay for NDV Infection
por: Wang, Bin, et al.
Publicado: (2014)

Myostatin negatively regulates satellite cell activation and self-renewal
por: McCroskery, Seumas, et al.
Publicado: (2003)

Development of a Recombinant Thermostable Newcastle Disease Virus (NDV) Vaccine Express Infectious Bronchitis Virus (IBV) Multiple Epitopes for Protecting against IBV and NDV Challenges
por: Tan, Lei, et al.
Publicado: (2020)

An intranasal recombinant NDV-BRSV F(opt) vaccine is safe and reduces lesion severity in a colostrum-deprived calf model of RSV infection
por: Sacco, Randy E., et al.
Publicado: (2022)

Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV
por: Roohani, Kiarash, et al.
Publicado: (2015)

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants
por: Muñoz-Alía, Miguel Á., et al.
Publicado: (2022)

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
por: Pitisuttithum, Punnee, et al.
Publicado: (2022)

Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms
por: Carreño, Juan Manuel, et al.
Publicado: (2021)

SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants
por: Kubale, John, et al.
Publicado: (2022)

Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice
por: Liu, Yonghong, et al.
Publicado: (2021)

A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2018)

Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein
por: Chumbe, Ana, et al.
Publicado: (2017)

Protection against Different Genotypes of Newcastle Disease Viruses (NDV) Afforded by an Adenovirus-Vectored Fusion Protein and Live NDV Vaccines in Chickens
por: Ferreira, Helena L., et al.
Publicado: (2021)

RECEPTOR DESTRUCTION BY VIRUSES OF THE MUMPS-NDV-INFLUENZA GROUP
por: Hirst, George K.
Publicado: (1950)

Recombinant Newcastle Disease Virus (NDV) Expressing Sigma C Protein of Avian Reovirus (ARV) Protects against Both ARV and NDV in Chickens
por: Saikia, Deep Prakash, et al.
Publicado: (2019)

NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice
por: Alqarihi, Abdullah, et al.
Publicado: (2019)

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
por: Sano, Kaori, et al.
Publicado: (2022)

Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Author Correction: A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2020)

The effects of different velogenic NDV infections on the chicken bursa of Fabricius
por: Kristeen-Teo, Y. W., et al.
Publicado: (2017)

Recombinant-attenuated Salmonella Pullorum strain expressing the hemagglutinin-neuraminidase protein of Newcastle disease virus (NDV) protects chickens against NDV and Salmonella Pullorum challenge
por: Ding, Ke, et al.
Publicado: (2018)

Recombinant Newcastle disease virus (NDV) expressing Duck Tembusu virus (DTMUV) pre-membrane and envelope proteins protects ducks against DTMUV and NDV challenge
por: Sun, Minhua, et al.
Publicado: (2018)

The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection
por: Singh, Shakti, et al.
Publicado: (2019)

Summary of worldwide pediatric malignancies reported after exposure to etanercept
por: McCroskery, Peter, et al.
Publicado: (2010)

Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters
por: García-Bernalt Diego, Juan, et al.
Publicado: (2023)

MECHANISM OF PRODUCTION OF PULMONARY LESIONS IN MICE BY NEWCASTLE DISEASE VIRUS (NDV)
por: Ginsberg, Harold S.
Publicado: (1951)

Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs
por: Lara-Puente, Jesús Horacio, et al.
Publicado: (2021)

Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program
por: Gold, Ralf, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vgni0tll8jh0qegsgtvgksnu6t